Molecular Tumor Board
After genomic test results were obtained, each case was discussed by the
Molecular Tumor Board, which consisted of specialists such as medical
oncologists, pathologists, radiologists, bioinformaticians, genetic
counselors, clinical research coordinators, and treating physicians.
These members discussed actionable genomic alterations and treatment
options on the basis of the patient’s medical history, treatment
history, family history, imaging findings, histopathological findings,
and genetic test results (8).